Actively Recruiting
Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty
Led by University of Alabama at Birmingham · Updated on 2026-04-28
60
Participants Needed
1
Research Sites
240 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid
CONDITIONS
Official Title
Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Skeletally mature patients aged 18 to 79 years
- Undergoing primary total shoulder arthroplasty
You will not qualify if you...
- Patients with cancer
- Patients with venous thromboembolism
- Patients with stroke
- Patients with heart disease
- Pregnant or nursing patients
- Patients allergic to tranexamic acid
- Current tobacco users
- Patients taking anticoagulants other than aspirin
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35205
Actively Recruiting
Research Team
W
Walter Smith
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here